238 related articles for article (PubMed ID: 24160292)
1. Hepatic cell lines for drug hepatotoxicity testing: limitations and strategies to upgrade their metabolic competence by gene engineering.
Donato MT; Jover R; Gómez-Lechón MJ
Curr Drug Metab; 2013 Nov; 14(9):946-68. PubMed ID: 24160292
[TBL] [Abstract][Full Text] [Related]
2. Cell lines: a tool for in vitro drug metabolism studies.
Donato MT; Lahoz A; Castell JV; Gómez-Lechón MJ
Curr Drug Metab; 2008 Jan; 9(1):1-11. PubMed ID: 18220566
[TBL] [Abstract][Full Text] [Related]
3. Human hepatocytes as a tool for studying toxicity and drug metabolism.
Gómez-Lechón MJ; Donato MT; Castell JV; Jover R
Curr Drug Metab; 2003 Aug; 4(4):292-312. PubMed ID: 12871046
[TBL] [Abstract][Full Text] [Related]
4. Human Upcyte Hepatocytes: Characterization of the Hepatic Phenotype and Evaluation for Acute and Long-Term Hepatotoxicity Routine Testing.
Tolosa L; Gómez-Lechón MJ; López S; Guzmán C; Castell JV; Donato MT; Jover R
Toxicol Sci; 2016 Jul; 152(1):214-29. PubMed ID: 27208088
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies.
Castell JV; Jover R; Martínez-Jiménez CP; Gómez-Lechón MJ
Expert Opin Drug Metab Toxicol; 2006 Apr; 2(2):183-212. PubMed ID: 16866607
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism.
Lin J; Schyschka L; Mühl-Benninghaus R; Neumann J; Hao L; Nussler N; Dooley S; Liu L; Stöckle U; Nussler AK; Ehnert S
Arch Toxicol; 2012 Jan; 86(1):87-95. PubMed ID: 21735230
[TBL] [Abstract][Full Text] [Related]
7. Critical differences in drug metabolic properties of human hepatic cellular models, including primary human hepatocytes, stem cell derived hepatocytes, and hepatoma cell lines.
Kvist AJ; Kanebratt KP; Walentinsson A; Palmgren H; O'Hara M; Björkbom A; Andersson LC; Ahlqvist M; Andersson TB
Biochem Pharmacol; 2018 Sep; 155():124-140. PubMed ID: 29953844
[TBL] [Abstract][Full Text] [Related]
8. A transcriptomic study suggesting human iPSC-derived hepatocytes potentially offer a better in vitro model of hepatotoxicity than most hepatoma cell lines.
Gao X; Liu Y
Cell Biol Toxicol; 2017 Aug; 33(4):407-421. PubMed ID: 28144825
[TBL] [Abstract][Full Text] [Related]
9. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
[TBL] [Abstract][Full Text] [Related]
10. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies.
Hewitt NJ; Lechón MJ; Houston JB; Hallifax D; Brown HS; Maurel P; Kenna JG; Gustavsson L; Lohmann C; Skonberg C; Guillouzo A; Tuschl G; Li AP; LeCluyse E; Groothuis GM; Hengstler JG
Drug Metab Rev; 2007; 39(1):159-234. PubMed ID: 17364884
[TBL] [Abstract][Full Text] [Related]
11. Upgrading HepG2 cells with adenoviral vectors that encode drug-metabolizing enzymes: application for drug hepatotoxicity testing.
Gómez-Lechón MJ; Tolosa L; Donato MT
Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):137-148. PubMed ID: 27671376
[TBL] [Abstract][Full Text] [Related]
12. Can hepatoma cell lines be redifferentiated to be used in drug metabolism studies?
Martínez-Jiménez CP; Jover R; Gómez-Lechón MJ; Castell JV
Altern Lab Anim; 2004 Jun; 32 Suppl 1A():65-74. PubMed ID: 23577436
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of potential hepatotoxicity induced by drugs.
Gómez-Lechón MJ; Lahoz A; Gombau L; Castell JV; Donato MT
Curr Pharm Des; 2010 Jun; 16(17):1963-77. PubMed ID: 20236064
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Modifications of the Liver Tumor Cell Line HepG2 Increase Their Drug Metabolic Capacity.
Ruoß M; Damm G; Vosough M; Ehret L; Grom-Baumgarten C; Petkov M; Naddalin S; Ladurner R; Seehofer D; Nussler A; Sajadian S
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654452
[TBL] [Abstract][Full Text] [Related]
15. Characterization of drug metabolizing activities in pig hepatocytes for use in bioartificial liver devices: comparison with other hepatic cellular models.
Donato MT; Castell JV; Gómez-Lechón MJ
J Hepatol; 1999 Sep; 31(3):542-9. PubMed ID: 10488716
[TBL] [Abstract][Full Text] [Related]
16. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery.
Sahi J; Grepper S; Smith C
Curr Drug Discov Technol; 2010 Sep; 7(3):188-98. PubMed ID: 20843293
[TBL] [Abstract][Full Text] [Related]
17. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
Gómez-Lechón MJ; Castell JV; Donato MT
Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells.
Rodríguez-Antona C; Donato MT; Boobis A; Edwards RJ; Watts PS; Castell JV; Gómez-Lechón MJ
Xenobiotica; 2002 Jun; 32(6):505-20. PubMed ID: 12160483
[TBL] [Abstract][Full Text] [Related]
19. The application of HepRG cells in evaluation of cytochrome P450 induction properties of drug compounds.
Andersson TB
Methods Mol Biol; 2010; 640():375-87. PubMed ID: 20645063
[TBL] [Abstract][Full Text] [Related]
20. 3D engineered In vitro hepatospheroids for studying drug toxicity and metabolism.
Chitrangi S; Nair P; Khanna A
Toxicol In Vitro; 2017 Feb; 38():8-18. PubMed ID: 27794450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
